Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.
about
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Clinical efficacy and safety o ...... , randomised controlled trial.
@en
Clinical efficacy and safety o ...... , randomised controlled trial.
@nl
type
label
Clinical efficacy and safety o ...... , randomised controlled trial.
@en
Clinical efficacy and safety o ...... , randomised controlled trial.
@nl
prefLabel
Clinical efficacy and safety o ...... , randomised controlled trial.
@en
Clinical efficacy and safety o ...... , randomised controlled trial.
@nl
P2093
P2860
P1476
Clinical efficacy and safety o ...... 3, randomised controlled trial
@en
P2093
CLEOPATRA Study Group
Caroline Murphy
Geoffrey B Arden
Helen Holmes
Joana C Vasconcelos
Joanna Kelly
Philip Hykin
Sheena George
Sobha Sivaprasad
P2860
P304
P356
10.1016/S2213-8587(18)30036-6
P50
P577
2018-03-05T00:00:00Z